Molecular genomics guides targeted uveal melanoma therapy

BOSTON — Uveal melanoma management is undergoing significant changes that enable improved survival for patients, improved globe retention and excellent visual acuity preservation, a speaker said here.Such management is possible when targeted genomics are evaluated and direct surgical laser ablation that avoids radiotherapy is used, according to Timothy G. Murray, MD, MBA, who spoke on the topic at the American Society of Retina Specialists meeting.

Full Story →